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Patents and Traditional Medicine:
Digital Capture, Creative Legal Interventions, and the
Dialectics of Knowledge Transformation
CHIDI OGUAMANAM*
ABSTRACT
This article examines the debate over the exclusion of indigenous or local knowl-
edge forms from the global intellectual property system, and some of the current at-
tempts to solve this problem. Using the lens of cultural cosmopolitanism, the article
highlights important trends in the dialectics of developing countries' engagement with
intellectual property and other collateral knowledge protection systems. The three sites
at which this significant development is unfolding are: (1) the digitization of tradi-
tional medicinal knowledge through India's traditional knowledge digital library
(TKDL) project; (2) a recent attempt at incorporating innovations in Chinese Herbal
Medicine (CHM) in Taiwanese patent law; and (3) efforts to enshrine disclosure of
origin requirements (DRs) in patent applications, and developments around geo-
graphical indications (Gls).
INTRODUCTION
The alternative to the divisiveness of one preeminent categoriza-
tion is not any unreal claim that we are all much the same. That we
are not. Rather, the main hope of harmony in our troubled world
lies in the plurality of our identities, which cut across each other
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School, Halifax, Nova Scotia, Canada. Aspects of this paper were presented at the 2008 Intellec-
tual Property Scholars Roundtable, Drake University, Des Moines, Iowa. Thanks to Professor
Peter K. Yu, Director, Intellectual Property Law Center at Drake, for inviting me to the Round-
table and to all participants for their feedback. I also thank Jerry I.-H. Hsiao of Queen Mary Intel-
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and work against sharp divisions around one single hardened line
of vehement division ....
Indigenous and local communities and developing countries in general have
a complex relationship with the intellectual property system. 2 From suspicion and
trepidation, they engage that system reluctantly, but often proactively. Beyond in-
tellectual property, they are also active participants in the debates around other
peripheral knowledge protection systems which are either collateral to or inde-
pendent of the intellectual property framework. Like the "dialectics of the colo-
nized mind,"3 indigenous peoples' attitude toward intellectual property reflects
both admiration, and disaffection or resistance. For instance, according to Mad-
havi Sunder, they "focus simultaneously on a defensive intellectual property pol-
icy, limiting rights in the context of essential medicines, and an offensive
intellectual property policy, seeking to expand intellectual property protection for
'poor people's knowledge' through mechanisms to protect biological diversity, tra-
ditional knowledge, and geographical indications."4
Popular accounts of the indigenous and local communities' ambivalent rela-
tionship with the intellectual property system reflect a hopeless state of frustra-
tion.' The dominant issues revolve around the suitability of the intellectual
property scheme to the overall conceptual thrust of indigenous or local knowl-
edge systems. Next to that is the search forsuigeneris knowledge protection mech-
anisms that are amenable to indigenous knowledge or, in the alternative, the quest
for the re-calibration of intellectual property philosophy to accommodate the exi-
1. AMARTYA KUMAR SEN, IDENTITY AND VIOLENCE 16 (2006).
2. For analytical convenience, references to indigenous peoples and/or local communities in
this paper apply to such categories in both developing and developed countries, and, in appropriate
places, emphasis is placed on the exigencies of developing countries without a conscious attempt to
distinguish between those countries and their indigenous and local communities.
3. SEN, supra note 1, at 85.
4. See Madhavi Sunder, IP3, 59 STAN. L. REV. 257, 297-98 (2006) (Sunder's observation is spe-
cifically directed to developing countries but it is aptly relevant to indigenous communities in the
developed world).
5. See e.g., Naomi Roht-A rriaza, Of Seeds and Shamans: The Appropriation of the Scientific and
Technical Knowledge of Indigenous and Local Communities, 17 MICH. J. INT'L L. 919,953-58 (1996);
Christine Haight Farley, Protecting Folklore of Indigenous Peoples: Is Intellectual Property the An-
swer?, 30 CONN. L. REv. 1, 12-40 (1997). Seealso VALUING LOCAL KNOWLEDGE: INDIGENOUS PEOPLE
AND INTELLECTUAL PROPERTY RIGHTS (Stephen B. Brush & Doreen Stanbinky eds., 1996) (examin-
ing proposals to treat cultural and indigenous knowledge as a form of intellectual property).
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gencies of the so-called non-Western knowledge forms.6 Even then, the suspicion
remains strong in developing countries and indigenous and local communities
about the long-term implication of unwholesome "appropriation of local knowl-
edge" into the intellectual property system. 7
A combination of factors, such as economic globalization, progress in genetic
research for food, drugs, and agriculture, as well as the escalating phenomenon of
biopiracy,s has made indigenous and local communities' ambivalence regarding
intellectual property an ill affordable option.9 These trends, aided by intellectual
property, each facilitate a unidirectional transfer of biological resources and asso-
ciated knowledge systems from developing countries to Western industrial com-
plexes with no benefit to their centers of origin." Consequently, developing
countries have resorted to diverse strategies, nationally and internationally, for the
protection of various aspects of their knowledge forms."
This article attempts to depart from the grim but popular accounts of devel-
oping countries' and indigenous and local communities' troubled experiences and
struggles with intellectual property and other mainstream knowledge protection
strategies. Using the lens of cultural cosmopolitanism, which reflects the blurring
of absolute distinctions across knowledge systems, this article highlights some im-
portant trends in the dialectics of developing countries' engagement with intel-
lectual property and other collateral knowledge protection systems. Drawing
6. See Dan Leskien & Michael Flitner, Intellectual Property Rights and Plant Genetic Resources:
Optionsfor a Sui Generis System, 6 ISSUES IN GENETIC RESOURCES 1, 43-65 (1997); Ikechi Mgbeoji,
Patents and Traditional Knowledge of the Uses of Plants: Is a Communal Patent Regime Part of the
Solution to the Scourge ofBio Piracy?, 9 IND. J. GLOBAL LEGAL STUD. 163, 173-75 (2001); Peter Dra-
hos, Indigenous Knowledge, Intellectual Property and Biopiracy: Is a Global Bio-Collecting Society the
Answer?, 22 EUR. INTELL. PROP. REV. 245, 247-50 (2000).
7 See Lester 1. Ya no, Comment, Protection of the Ethnobiological Knowledge of Indigenous Peoples,
41 UCLA L. REV. 443, 485-86 (1993). Seealso Arun Agrawal, On Powerand Indigenous Knowledge,
in CULTURAL AND SPIRITUAL VALUES OF BIOLOGICAL DIVERSITY 177 (Darrel A. Posey ed., 2000).
8. Generally, biopiracy is a loose reference to unidirectional appropriation ofbiocultural knowl-
edge and associated biological resources of indigenous and local communities by external interests
or second comers.
9 See Chidi Oguamanam, Intellectual Property Rights in Plant Genetic Resources: Farmers' Rights
and Food Security of Indigenous and Local Communities, II DRAKE J. AGRIC. L. 273, 278 (2006).
10. Anupam Chander & Madhavi Sunder, The Romance of the Public Domain, 92 CAL. L. REv.
1331, 1346-47 (2004).
11. For an overview of these strategies and institutional sites in which they are canvassed, see
Laurence R. Helfer, Regime Shifting: The TRIPS Agreement and New Dynamics of International
Intellectual Property Lawmaking, 29 YALE J. INT'L L. 1, 10-52 (2004) and Ruth L. Okediji, Back to
Bilateralism? Pendulum Swings in International Intellectual Property Protection, I U. OTTAWA L. &
TECH. J. 125, 136-42 (2004).
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from ongoing developments, especially those concerning traditional medicine, I
argue that one of the major, albeit unsuspecting, outcomes of the pressure which
local knowledge poses for the intellectual property system is that it has opened an
opportunity for conversation across knowledge systems, strategically empowering
indigenous or local knowledge in the process. I am more concerned with the sym-
bolic ramifications of this trend than with its overall translation and impact in
regard to actual leveraging of traditional knowledge forms. The significance of
the trend lies in the empirical support and irresistible credence it bequeaths to the
thesis of cultural cosmopolitanism. Also, it points to the importance of reflective
consciousness regarding the limits of the overarching binary classification of
knowledge systems into the Western and non-Western that corresponds, even if
arguably, to the cosmopolitan and local epistemic divide.
For the purpose of the present exercise, this article does not explore the contro-
versies over the merits or demerits of the presumed cosmopolitan and local status of
Western and non-Western knowledge systems. 2 Nor does it seek to inquire into the
presumed and often contested scientific status of the two knowledge systems. 3 In
contemporary times, the deceptive alliance between appearance and reality, which
is analogous to law's perception of possession and ownership, helps to sustain these
presumptions. Categorizations of the status of "knowledge" are hardly absolute,4
12 In diverse contexts, cosmopolitanism itself is a contested term, especially when used in juxta-
position with "local." For example, in some quarters, cosmopolitanism is a reference to creolization
or hybridization of knowledge or cultural practices as counterpoint to homogeneity; in other cases,
it depicts an unending state of conflict and struggle for emancipation between local and "translocal"
or dominant tendencies. See generally WILL KYMLICKA, MULTICULTURAL ODYSSEYS: NAVIGATING THE
NEW INTERNATIONAL POLITICS OF DIVERSITY (2007) (identifying the moral dilemmas and political
complexities raised by international efforts to diffuse multiculturalism); WILL KYMLICKA, LIBERAL-
ISM, COMMUNITY AND CULTURE (1989) (arguing that the resources available within the liberal view
of culture have been misunderstood); BOAVENTURA DE SOUSA SANTOS, TOWARD A NEW COMMON
SENSE: LAW, SCIENCE AND POLITICS IN THE PARADIGMATIC TRANSITION (1995); Ulf Hannerz, Cosmo-
politans and Locals in World Culture, in GLOBAL CULTURE: NATIONALISM, GLOBALIZATION AND MO-
DERNITY 237-51 (Mike Featherstone ed., 1990) (discussing the globalization of culture); Jeremy
Waldron, Minority Cultures and Cosmopolitan Alternatives, in THE RIGHTS OF MINORITY CULTURES
93 (Will Kymlicka ed., 1995) (exploring the tension between what is implicit in the affirmation of
cosmopolitanism and the individual views created out of cultural immersion).
13. See generally LOCAL SCIENCE VS. GLOBAL SCIENCE: APPROACHES TO INDIGENOUS KNOWLEDGE
IN INTERNATIONAL DEVELOPMENT (Paul Sillitoe ed., 2007) (arguing for the need to acknowledge
that the social positioning of knowledge is culturally embedded).
14. See CHIDI OGUAMANAM, INTERNATIONAL LAW AND INDIGENOUS KNOWLEDGE: INTELLECTUAL
PROPERTY, PLANT BIODIVERSITY, AND TRADITIONAL MEDICINE 15-18 (2006); Arun Agrawal, Dis-
mantling the Divide Between Indigenous and Scientific Knowledge, 26 DEV. & CHANGF 413, 416-20
(1995); Arun Agrawal, Indigenous and Scientific Knowledge: Some Critical Comments, 3 INDIGENOUS
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and, for good reasons, they are open to continued interrogation. For example, de-
spite the significant and historic contributions of Arab and Muslim societies to sci-
ence and mathematics, Amartya Sen observes that "crude classifications have tended
to put science and mathematics in the basket of 'Western science,' leaving other peo-
ple to mine their pride in religious depths."'5 The same is true of the appropriation
of Egyptian and African contributions to what is now called "Western medicine."'6
Cultural cosmopolitanism itself is a postmodern concept that inherently impli-
cates the symbiotic relationship between knowledge and culture.'" It stems mainly
from contemporary anthropologists', legal anthropologists', and political philoso-
phers' reservations about the rigid classification or bifurcation of knowledge sys-
tems." Their central argument is that knowledge and culture are not static; they are
constantly negotiated, and they evolve in a processual manner. The evolution of
knowledge follows a pattern of "creative mixing"-creative borrowing and creoliza-
tion across knowledge systems. 19 This trend is integral to the ubiquitous phenome-
non of globalization.
Cultural cosmopolitanism is an attractive theoretical alternative to the now
discredited notion of culture as a static and isolated phenomenon which has lost
favor in anthropological circles. That discredited approach provided intellectual
support for rigid and near absolute demarcations of knowledge frameworks into,
for example, Western scientific and non-Western or local epistemic systems. In its
broad application, cultural cosmopolitanism problematizes absolute qualifications
or claims to knowledge that are insensitive to the traffic and exchange of informa-
KNOWLEDGE AND DEVELOPMENT MONITOR 1, 2-4 (1995), available at http://www-personal.umich.
edu/-arunagra/papers/IK%20 Monitor%203 (3)%20Angrawal.pdf.
15. SEN,Supra note 1, at 15.
16. See COLLINS 0. AIRHIHENBUWA, HEALTH AND CULTURE: BEYOND THE WESTERN PARADIGM
51-54 (1995); CHEIKH ANTA DiOp, PRECOLONIAL BLACK AFRICA: A COMPARATIVE STUDY OF THE
POLITICAL AND SOCIAL SYSTEMS OF EUROPE AND BLACK AFRICA, FROM ANTIQUITY TO THE FORMA-
TION OF MODERN STATES 205-206 (Harold J. Salemson trans., 1987) (pointing out that empirical
medicine, including diverse forms of surgical procedures like cataract, shrapnel and bullet extrac-
tion, wound cauterization, etc. utilizes aspects of African medical traditions from antiquity).
17. Seegenerally LOCAL SCIENCE VS. GLOBAL SCIENCE,SUpra note 13.
18. See, e.g., Olufunmilayo B. Arewa, TRIPS and Traditional Knowledge: Local Communities,
Local Knowledge, and Global Intellectual Property Frameworks, 10 MARQ. I NTELL. PROP. L. REV. 155,
164-66 (2006); Michael F. Brown, Can Culture Be Copyrighted?, 39 CURRENT ANTHROPOLOGY 193,
197-99 (1998); Olufunmilayo B. Arewa, Piracy, Biopiracy and Borrowing: Culture, Cultural Heri-
tageandthe Globalization of Intellectual Property, 68-72 (Berkeley Electronic Press, Working Paper
No. 1114, 2006) available at http://law.bepress.como/expresso/eps/lll41 [hereinafter Piracy,
Biopiracy and Borrowing]. See generally supra note 12 and accompanying text.
19. Brown,supra note 18, at 196.
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tion across knowledge or cultural systems. 20 Specifically, it has been used to inter-
rogate indigenous peoples' exclusive claims over their traditional knowledge via
intellectual property rights." Despite its persuasion, the notion of cultural cosmo-
politanism could not obliterate logical markers that distinguish knowledge sys-
tems, no matter how inconclusive they may be.22 However, it calls attention to the
limits of a narrow and "single hardened line of vehement division23 across knowl-
edge systems and the potential of such systems to cut across or interact with one
another for the collective benefit of humanity.
The bifurcation of knowledge systems along Western and non-Western cate-
gories and their cosmopolitan and local correlation are symbolically illustrated in
the distinction usually made between Western orthodox medicine and traditional
medicine,2 4 broadly construed. Writing in specific reference to Chinese Herbal
Medicine (CHM), Jerry I.-H. Hsiao makes the following observation, which is
largely true for the rest of traditional medicine or complementary and alternative
medicine (CAM). He notes:
CHM differs from Western medicine in its basic orientation, physi-
ological theories, etiology, diagnostics, therapeutics and pharma-
cology. The major difference between CHM and Western medicine
is their fundamental difference in medical theories. While West-
ern medicine adopts the Cartesian reductionism approach separat-
ing the body and the mind, CHM is holistic. CHM is an art as well
as a science. 25
20. See Oguamanam,supra note 9, at 298-300.
21. See Piracy, Biopiracy and Borrowing, supra note 18, at 65-68. See generally Brown, supra note
18 (assessing the legal schemes proposed to control cultural appropriation).
22. See Chidi Oguamanam, Local Knowledge as a Trapped Knowledge: Intellectual Property, Cul-
ture, Power and Politics, 11 IJ. WORLD INTELL. PROP. 29 (2008).
23. SEN, supra note 1, at 16.
24. Generally, traditional medicine is also referred to as Complementary and Alternative Medi-
cine (CAM). Traditional medicine or CAM is not, however, a single category. It is a federation of
medical systems which are rooted in strong independent or interdependent theories and philoso-
phies of medicine that are readily distinguishable from western orthodox medicine. According to
the U.S. National Centre for Complementary and Alternative Medicine (which is part of the Na-
tional Institutes of Health), "CAM is a group of diverse medical and health care systems, practices,
and products that are not presently considered to be part of conventional medicine." NCCAM,
What is CAM? 1 (Feb. 2007), http://nccam.nih.gov/health/whatiscam/pdf/D347.pdf.
25. Jerry I.-H. Hsiao, Patent Protection for Chinese Herbal Medicine Product Invention in Taivan,
10 J. WORLD INTELL. PROP. 1, 4 (2007) (citation omitted).
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Similarly,
in traditional therapeutic systems, humanity is an integrated being;
united in mind, body and soul. The unity of mind and body is
linked to the desired unity between the individual and her larger
community, as the primary aim of traditional therapy. Treatment
... is approached from a holistic perspective.2 6
Ironically, despite being the source of medical relief for 80 percent of the global
population, traditional medicine and its associated knowledge are perceived as a
form of local knowledge, in contrast to Western biomedicine. A number of factors
account for the presumed local status of traditional medicine, and the cosmopolitan
status of its Western counterpart. The most critical factor is the colonial hierarchy of
culture and power in which non-Western peoples and their knowledge systems are
treated with disdain and derogation.2 7 Other factors relate to the formal approach of
biomedicine, manifested in part by its historical claims to being exclusively scientific
and, by inference, universal in relation to other systems of medicine. 8 Closely related
to these is the association of science in general, and medical science in particular,
with the "Western," especially in accordance with the Cartesian tradition. 9 The
strong global presence and visibility of all things "Western" is a logical, albeit ques-
tionable, basis of entitlement to cosmopolitanism.
Intellectual property, particularly the patent regime, is an important factor in
26. Chidi Oguamanam, Between Reality and Rhetoric: The Epistemic Schism in the Recognition
of Traditional Medicine in International Law, 16 ST. THOMAS L. REv. 59, 97 (2003). See also Bonnie
B. O'Connor & David I. Hufford, Understanding Folk Medicine, in HEALINc Locics: CULTURE AND
MEDICINE IN MODERN HEALTH BELIEF SYSTEMS 13-19 (Erica Brady ed., 2001).
27. See DUNCAN IVISON, POSTCOLONIAL LIBERALISM 35 (2002); Piracy, Biopiracy and Borrowing,
supra note 18, at 33-37; Oguamanam,supra note 22.
28. See Chidi Oguamanam, Biomedical Orthodoxy and Complementary and Alternative Medicine:
Ethical Challenges of Integrating Medical Cultures, 12 1. ALTERNATIVE & COMPLEMENTARY MED. 577,
577 (2006); P.R. Wolpe, Alternative Medicine and the AMA, in THE AMERICAN MEDICAL ETHICS
REVOLUTION: How THE AMA's CODE OF ETHICS HAS TRANSFORMED PHYSICIANS' RELATIONSHIP TO
PATIENTS, PROFESSIONALS AND SOCIETY 218 (R.B. Baker et al. eds., 1999).
29. Rend Descartes is a 16th century French philosopher who is credited with the exploration of
the scientific method of reduction in the exploration of complex philosophical problems. This ap-
proach was very fundamental in the evolution of biomedicine through its treatment of the human
body according to its component parts and offering its therapeutic approach as a targeted organis-
mic intervention. This contrasts sharply with the holistic thrust of the diverse ideologies of tradi-
tional medicine.
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the privileging of Western medicine over traditional medical systems." However,
methods of medical treatment are excluded from virtually all national patent re-
gimes." Consequently, the impact of intellectual property on medical care deliv-
ery turns mainly on pharmaceutical innovations, including access to drugs, related
products, and various other medical technological innovations other than meth-
ods of treatment. In traditional medicine, the pharmacological process involves
mainly the exploitation of natural products such as plants, animals, and minerals
in accordance with underlying theories of health and healing. 2 In most cases, the
holistic nature of traditional medicine means the fusion of the therapeutic with
the pharmacological.33
Conversely, in Western medicine, the pharmacological and medical processes
are separate. In accordance with the Cartesian approach, Western medicine is de-
signed to identify, isolate, and purify the active substance, or create its synthetic
alternative, with a view to pointedly account for its function in the therapeutic
process. It also adopts an organismic account of disease and a reductionist under-
standing of the human anatomy as separate from the mind and as a component of
diverse parts that can be targeted for therapeutic intervention.34
The methodological and ideological dichotomy between Western and tradi-
tional medicine resonates in the direct exclusion of traditional medicine from the
patent process.35 In its checkered evolution in the West, the patent system is at-
tuned to the processes and products of Western scientific innovation. Its technical
details have little problem legitimizing pharmacological processes, products, and
related innovations as a component of Western medicine. On the contrary, tradi-
tional medicine is a stranger to the patent process. Patent law's discrimination
against forms of local knowledge fosters the notorious bifurcation of knowledge
systems along Western (scientific) and non-Western (non-scientific) praxis. The
30. See Chidi Oguamanam, Localizing Intellectual Property in the Globalization Epoch: The In-
tegration of Indigenous Knowledge, 11 IND. J. GLOBAL LEGAL STUD. 135, 149 (2004).
31. See, e.g., Final Act Embodying the Results of the Uruguay Round of Multilateral Trade
Negotiations, Apr. 15, 1994, Agreement on Trade-Related Aspects of Intellectual Property Rights,
annex IC, art. 27,33 I.L.M. 1125, 1208 (1994).
32. See Hsiao, supra note 25, at 4-5; O'Connor & Hufford, supra note 26, at 29; Oguamanam,
supra note 26, at 73-75. See generally CECIL G. HELMAN, CULTURE, HEALTH AND ILLNESS (4th ed.
2000) (addressing the clinical significance of, and complex interactions between, health, illness and
culture).
33. OGUAMANAM,SUpra note 14, at 126.
34. Id. at 112-13. See also Oguamanam, supra note 26, at 96-98.
35. Oguamanam, supra note 26, at 112-13; Oguamanam,supra note 30, at 135-36; Yano,supra
note 7, at 444-45; Agrawal, supra note 7, at 177-78.
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failure of the intellectual property system, especially the patent domain, to take
traditional medicine and traditional knowledge seriously has been a source of dis-
quiet in the world of indigenous and local communities and in the developing
countries. 6 It reinforces the distrust accorded to the current intellectual property
regime and, simultaneously, raises passion and pressure for the revision of its con-
ceptual framework in a manner typical of the dialectics of non-Western people's
attitude to the intellectual property system.
Intellectual property's hardening of the stubborn division between Western
medicine and biomedicine is not sensitive to the reality of cultural cosmopolitan-
ism and creolization in the medical knowledge arena. However, developments in
the traditional medicine and genetic resources arena in the last five years suggest
that developing countries have adopted a radically different strategy in their ap-
proach to intellectual property which may have positive implications for local
knowledge. 7 Unconsciously, they have sought to renegotiate the so-called local
status of traditional medicine through foisting the latter on the formal patent sys-
tem in what translates into a direct encounter between the local and the cosmo-
politan. In this way, they not only seek to empower traditional medicine but, by
default, they confront the intellectual property system with the reality of cultural
cosmopolitanism and the processual evolution of knowledge. In the following
three sections, I explore the sites for this revolutionary strategy, highlighting its
significance as modest yet constituting a paradigmatic shift in indigenous and
36. This vacuum in the intellectual property system is one of the pivotal sources of tension in the
international intellectual property lawmaking process. It often pitches developing and developed
countries against each other. In the last decade, the tensions have been heightened by the concerted
pressure exerted by developing countries for a review of the TRIPS Agreement, among other
things, to accommodate the contributions of the knowledge of indigenous and local communities.
Recent discourses of this trend are captured by the concept of "regime shifting" or "regime ten-
sion" in the intellectual property system. See, e.g., Marney L. Cheek, The Limits ofInformal Regula-
tory Cooperation in International Affairs: A Review of the Global Intellectual Property System, 33
GEO. WASH. INT'L L. REV. 277, 293-95 (2001); Heifer, supra note 11 at 4-6; Chidi Oguamanam,
Regime Tension in the Intellectual Property Rights Arena: Farmers' Rights and Post-TRIPS Counter
Regime Trends, 29 DALHOUSIE L. J. 413 (2006); Okediji, supra note 11, at 128-29; Ruth L. Okediji,
The International Relations of Intellectual Property: Narratives of Developing Countries Participation
in the Global Intellectual Property System, 7 SING. I. INT'L & CoMp. L. 315, 337-39 (2003); Peter Yu,
Current and Cross-Currents in the International Intellectual Property Regime, 38 Loy. L.A. L. REV.
323,373-74 (2004). Furthermore, the growing literature on biopiracy discusses and assails the lack
of entrenchment of local knowledge in the international intellectual property system. See, e.g.,
Ikechi Mgbeoji, GLOBAL BIOPIRACY: PATENTS, PLANTS AND INDIGENOUS KNOWLEDGE II (2006).
37. This is demonstrated in this article through examples drawn from the Traditional Knowl-
edge Digital Library (TKDL) project, the Disclosure of Origin (DRs), Geographical Indications
(GIs), and various other legal interventions.
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local communities' approach to, and experience with, the intellectual property
establishment. It remains to be seen to what extent this strategy could potentially
position local knowledge within the structure, content, and conceptual frame-
work of conventional intellectual property.
This article will discuss the three sites at which this significant development
is unfolding: 1) the digitization of traditional medical medicine through India's
traditional knowledge digital library (TKDL) project (Part I); 2) a recent attempt
at incorporating innovations in CHM in Taiwanese patent law (Part II); and 3)
efforts to enshrine disclosure of origin requirements (DRs) in patent application,
and developments around geographical indications (GIs) (Part III).
I. DIGITAL CAPTURE OF TRADITIONAL MEDICINE
A. The Indian Initiative
India, indeed, the Indian subcontinent, has a rich heritage in traditional me-
dicinal knowledge. This heritage derives from multiple medicinal traditions, in-
cluding Ayurveda, homeopathy, naturopathy, Siddha, Unanani, and Yoga.38 Even
though the bulk of this knowledge has been handed down by oral tradition, sig-
nificant parts of it are described in diverse but usually inaccessible classical litera-
ture in different traditional or local languages such as Hindi, Sanskrit, Urdu,
Tamil, and others. Despite their inaccessibility, their age-long codification war-
rants according them public domain status. In recent times, transnational phar-
maceutical corporations and research institutions have exploited India's medicinal
heritage through the patent system. Notable examples include the turmeric, bas-
mati, and neem patents, the applications for which were the subject of controversy
at the United States Patent and Trademark Office (USPTO), the European Pat-
ent Office (EPO), and elsewhere.3 9 The experience became a wake-up call for
India to address the nagging issue of the exploitation of its traditional medicinal
heritage and the scourge of biopiracy, just like the Soviet launch of the Sputnik
38. See OGUAMANAM,supra note 14, at 120-21.
39. See, e.g., Arewa, TRIPS and Traditional Knowledge, supra note 18, at 170-79 (providing de-
tailed accounts of such biopiracy); Murray P. Eiland, Patenting Traditional Medicine, 89 J. PAT. &
TRADEMARK OFF. Soc'Y 45, 62-69 (2007); Emily Marden, The Neem Tree Patent: International
Conflict Over the Commodification of Life, 22 B.C. INT'L & COMP. L. REV. 279 (1999) (discussing the
neem tree patent).
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pushed America to seriously engage itself in the space race.4" India's experience is
representative of a general trend in many developing countries with rich genetic
resources and a traditional knowledge heritage.
India's response to the rampant biopiracy was the establishment of a defensive
anti-appropriation strategy, the TKDL. This approach is an aggressive attempt to
make previously inaccessible but codified Indian traditional medicinal knowledge
available in digital form, so that patent examiners will have them handy as evi-
dence of prior art (i.e., pre-existing knowledge), with a view to scuttling subse-
quent frivolous or biopiracy patents.4" The TKDL for India's systems of medicine
is a massive state-sponsored interdisciplinary and interdepartmental project. It de-
ploys the nation's wealth of human resources in medicinal knowledge systems,
information technology, science, research, and bureaucracy.4 2 According to its
manifesto, "[t]he project.., involves the documentation of the knowledge avail-
able in Ithe] public domain on traditional knowledge from the existing literature
related to Ayurveda, Unani and Siddha, in digitalized format in five international
languages which are English, German, French, Japanese and Spanish."43 Throw-
40. The Sputnik was the first satellite to go beyond the earth's atmosphere and to orbit the planet.
Its launch in October 1957 marked the beginning of the Space Age. It was a development that sur-
prised the United States and pushed it to massively invest in science and technology that would assert
the United States as a space power, a status which became a critical asset in the Cold War era.
41. The ambitious nature of the TKDL project is reflected in the intensity of its execution. In
March 2007, Vinod Kumar Gupta reported the following statistics: Altogether, 148 books compris-
ing 230 volumes of Ayurveda, Unani, Siddha and Yoga are being used for the TKDL project. Sixty-
four books of ninety volumes address Ayurveda with an anticipated 76,000 formulations. Unani
TKDL is being derived from nineteen books of sixteen volumes. Both Ayurveda and Unani are in
the same format and languages: Urdu, Arabic and Persian. Targeted formulations for Siddha are
anticipated to be 12,000 derived from 45 Tamil texts of 53 volumes. Yoga TKDL is projected to be
created from 150 posture images from 20 books and 24 million pages of information have been cre-
ated out of the projected 31 million pages for 2007. These statistics show that in the five years in
which TKDL has been active, it has exceeded most of its projections. See Vinod Kumar Gupta,
India, TKDL: Definition and Classification of Intangible Cultural Heritage and Traditional Knowledge
in the Context of Inventory Making, at 20 (paper delivered at the Conference on Intangible Cultural
Heritage and Intellectual Property Under the 2003 UN Convention for the Safeguarding of Intan-
gible Cultural Heritage, New Delhi, India, March 25-27,2007) (on file with author).
42. The collaborating institutions include the National Institute of Science Communication
and Information Resources (NISCAIR), Council of Science and Industrial Research, Ministry of
Science & Technology and the Department of Ayurveda, Yoga, Unani, Siddha and Homeopathy
(AYUSH) and Ministry of Health and Family Welfare. The project is being implemented at the
NISCAIR. This author was privileged to participate in a guided tour of the TKDL in the spring
of 2007 and had an opportunity to interview some staffers of the project at NISCAIR.
43. About TK DL, http://www.tkdl.res.in/tkdl/langdefault/common/Abouttkdl.asp ?GL =Eng
(last visited May 20, 2008).
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ing further light on the process, the Director of India's National Institute of Sci-
ence Communication and Information Resources (NISCAIR) where the project
is being implemented, V.K. Gupta, avers that the
TKDL database acts as a bridge between ancient traditional
knowledge in the original languages (which may be in Hindi, San-
skrit, Urdu, Persian, Arabic, Tamil, etc.) and a patent examiner at
a global level, since the database will provide information on mod-
ern as well as local names in a language and format understand-
able to patent examiners. The gap in prior art knowledge is
minimized. The prior art has sufficient details on definitions, prin-
ciples, and concepts to minimize the possibility of getting accepted
minor insignificant modifications as novelty.44
Experts involved in the TKDL project include those in traditional knowledge
classification and those knowledgeable in international patent classification prac-
tices. Also included are information technology (IT), language, and translation/
transcription experts. The IT experts create and provide technical support for the
software and portal, while the traditional knowledge experts identify the formula-
tions and incorporate them into the database after editing and verification.
India's decision to digitally document codified forms of its rich traditional
medicinal heritage reflects the dialectics of developing countries' relationship with
intellectual property and other knowledge protection systems. For instance, as a
defensive mechanism, the TKDL's principal objective is to thwart potential or
existing biopiracy patents or the tendency by second-comers or strangers to exploit
India's traditional medicinal knowledge. India is, however, conscious of the po-
tential intellectual property spin off of the project, especially through research
and collaborative investment with foreigners interested in the use of the knowl-
edge.45 Conceptually, therefore, the TKDL is not necessarily limited to a patent-
related prior art search. Conscious effort is directed at guarding against its
subversion for potential counter-productive outcomes, such as when information
in the TKDL is mismanaged in a way that facilitates biopiracy. In this regard, the
access and use of the TKDL database is subject to an agreement that imposes a
restrictive obligation on those who legitimately possess the database and are in a
44. See Gupta, supra note 41, at 9.
45. See id.
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position to make it accessible to third parties.46 Those in this privileged position
include national and regional patent offices that need the TKDL databases to as-
sist them in conducting prior art searches. 47
One of the most significant contributions of the TKDL project within its
short period of existence is its success in the proactive integration of its database
"with the international intellectual property office activity of search and examina-
tion of the prior art search systems."' s For instance, the TKDL has improved on
the problem associated with the classification system regarding the documenta-
tion of traditional knowledge. It has done this by creating a modern classification
system fashioned after the framework of the International Patent Classification
(IPC). The resulting classification, which so far covers only Unani and Ayurveda
medicinal systems, is ambitiously called the Traditional Knowledge Resource
Classification (TKRC). The IPC was created pursuant to the World Intellectual
Property Organization (WIPO) administered multilateral treaty, the Strasbourg
Agreement Concerning the International Patent Classification.49 It provides a hi-
erarchical system in which technological or innovation categories are divided into
a range of sections, classes, and subclasses for easy identification in prior art ex-
amination.0 Patent offices of more than one hundred countries, other intellectual
property regional offices, as well as the International Bureau of the WIPO and
the Patent Corporation Treaty (PCT) rely on the IPC for prior art searches.5
The Indian initiative on the classification of traditional knowledge within the
IPC has resulted in a detailed and improved IPC structure relating to traditional
medicine. This includes the 2003 decision by the IPC Union to expand the classi-
fication of medicinal plants by about two hundred subgroups via the creation of a
brand new group (A61K36) and, perhaps most importantly, the linkage of IPC
with the TKRC through a concordance table prepared by India. 2 Currently, the
46. The NISCAIR has a sample access agreement as part of its brochure (on file with author).
47. As Traditional Knowledge Resource Classification (TKRC) becomes part of the Interna-
tional Patent Classification (IPC) system, the TKDL database is now an integral part of interna-
tional and national patent administration.
48. Gupta,supra note 41, 14.
49. Strasbourg Agreement Concerning the International Patent Classification, Mar. 24, 1971,26
U.S.T. 1793.
50. See WIPO, Preface to the International Patent Classification, http://www.wipo.int/classifications/
ipc/en/ general/preface.html (last visited July 12, 2008) (discussing the eight sections (A-H), with an es-
timated 70,000 subclasses under the I PC).
51. Id.
52. This was a recommendation of a concerted committee of experts meeting of the IPC held in
February 2001. The committee's decision was received positively by a WI PO-TK Task Force. The
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TKRC includes about 500 subgroups for medicinal plants, whereas IPC con-
tained only one subgroup (i.e., A61K35/78).5 In its operational modem system,
the TKDL software incorporates the novel classification system, TKRC, and con-
verts documented knowledge into target languages. In essence, medicinal formu-
lations codified in ancient texts on Indian systems of medicine are transcribed or
decoded into patent application formats in five so-called international languages
under the meticulous supervision of scientists, technical officers, and distinguished
experts in the particular systems of medicine. As opposed to transliteration,
[l]t [the software] does knowledge based conversion where data ab-
stracted once is converted into several languages by using state of the
art technology such as Unicode, XML and metadata methodology.
Software also converts traditional terminology into IWestern scientific]
modern terminology, for example, Kumari (local name) to Aloe bar-
badensis, Masurika (Sanskrit name for a disease) to small pox, etc. 4
In general, the TKDL software is designed to translate local and previously
inaccessible information buried in India's traditional medicinal knowledge heri-
tage into their modern scientific correlation, which patent examiners can readily
use for prior art searches.
The digital capture of traditional medicinal knowledge has given new momen-
tum to traditional knowledge in many respects.55 Interestingly, the popular and lon-
ger standing policy responses to intellectual property's problematic relationship with
traditional knowledge remain inchoate and do not seem to have translated into any
concrete results, let alone one with as much practical impact as the TKDL initia-
tive.56 Specifically, the TKDL has fueled an epistemological encounter and dialogue
latter comprised the USPTO, EPO, China, Japan and India, which the IPC expert committee
rallied when it was presented with India's proposal for the TKRC. See Gupta supra note 41, at 3.
The decision to link the TKRC with the I PC was taken at the 35th extraordinary meeting ofcom-
mittee of experts of the IPC Union in October 2004.
53. See TRADITIONAL KNOWLEDGC DIGITAL LIBRARY USER MANUAL 1 (a joint, undated publica-
tion of AYUSH, NISCAIR and the Controller General of Patents, Designs and Trade Marks,
India) (on file with author).
54. Gupta,supra note 41, at 12.
55. See Chidi Oguamanam, Documentation/Digitizing of Traditional Knovledge and Intangible
Cultural Heritage: Challenges and Prospects (forthcoming 2008) (discussing the pros and cons of
traditional knowledge documentation, including the TK DL project).
56. For the most part, the literature focusing on this problem seems to dwell on the conceptual
conflict between traditional knowledge and intellectual property rights, while making a case for
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between traditional medicine as a local knowledge form and its more cosmopolitan
Western counterpart through the direct attempt to increase traditional medicine's
stake within the patent system. Even though digitization of traditional medicine
through the TKDL primarily aims at establishing aspects of its standing as prior
art, it must be noted that preexisting patents, like those associated with Western
medicine, are prima facie prior art. To that extent, the TKDL calibrates, or levels
up, traditional medicine with its Western counterpart. This creates a semblance of
psychological parity in favor of traditional medicinal knowledge vis-A-vis the extant
recognition of Western scientific medicine under the patent regime. The difference
is that while traditional medicine-related knowledge may be, at least in theory, freely
accessible because it is part of the public domain, its Western biomedical or scientific
counterpart is protected for the term of any applicable patent. Like the conventional
patent system, the TKDL does not directly address the exclusive and proprietary
aspects of traditional medicine. However, by creating a new classification system
based on traditional medicine (i.e., the TKRC), and by informing the IPC and
global patent literature, the TKDL "provides a bridge between modern science,
modern medicines and traditional knowledge."57
Beyond bridging, the TKDL's adoption of the concordance methodology to
entrench traditional medicine in the IPC system exposes the interaction, interrela-
tionship, and creolization between Western medicine and traditional medicine in
a way that blunts the sharp and uncritical loyalty to the prevalent rigid classifica-
tion of the two knowledge forms. Even though the TKDL deals with codified
information on traditional medicine in the public domain, as a permanent and
growing feature of the global patent process, the TKDL promises to be of signifi-
cant importance for the patentability of non-codified and independent traditional
medicinal innovations.
In addition to being a new initiative that is barely five years old, the limitations
of the TKDL are quite obvious. For instance, its associated TKRC is limited, at
least, for now, to Ayurveda and Unani entries. Also, in its present form, it seems to
narrowly focus on codified aspects of India's traditional medicinal system and does
not address non-codified systems. Lastly, it is a state-sponsored initiative in which
the extent of involvement of traditional custodians of the traditional medicinal heri-
tages is not quite clear. Consequently, there is a limit to which the benefits of the
digital capture of traditional medicine could be stressed. It is, however, evident that
expanding the intellectual property framework to accommodate local knowledge via, inter alia, a
variety of sui generis models of intellectual property protection.
57. Gupta,supra note 41, at 7.
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TKDL offers symbolic credence to the theory of cultural cosmopolitanism, in addi-
tion to covertly opening up the patent system to traditional medicine in a local ver-
sus cosmopolitan encounter. In any case, the importance of TKDL appears to lie
mostly in its potential to spread to other developing countries in a way that will fur-
ther enable traditional knowledge to infiltrate the patent system.
B. TKDL Outside India
Indeed, since the Indian-initiated TKDL was established, it has proven to be
inspirational to several countries and regional intellectual property and economic
groups desirous of tackling the appropriation of their traditional knowledge re-
sources. At present, India is providing support for the creation of TKDL for the
South Asian Association for Regional Cooperation (SAARC) comprising Afghani-
stan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka.58 The
Cameroon-based African Regional Industrial Property Organization (ARIPO) has
also expressed interest in an African regional TKDL. 9 Several individual countries,
including South Africa, Mongolia, and Thailand have expressed the interest to en-
gage in similar national initiatives.6 ° Thus, despite its present and inherent practical
and conceptual limitations, the TKDL is a potential mechanism to aid the emanci-
pation of traditional knowledge and propel it into the conventional intellectual
property system. In a way, it also demonstrates the practical relevance of the cultural
cosmopolitanism thesis in the medical field.
Because it directly targets the scourge of biopiracy, the Indian TKDL initia-
tive resonates with the majority of gene-rich developing countries. Other attempts
to directly engage local knowledge with the intellectual property system are ex-
emplified in the national initiatives of individual countries. Tackling biopiracy is
not necessarily the motivation for this approach, in which the affected countries
are determined to work within the framework of national patent laws and other
nuanced policy options to empower traditional medicine. As demonstrated in the
following discussions of the developments in China, Taiwan, and elsewhere, each
country's approach is dictated by its peculiar or strategic national interest and
comparative advantage.
58. For information on this regional organization, see http://www.saarc-sec.org/main.php (last
visited May 20, 2008). See also Eiland,supra note 39, at 65.
59. See OGUAMANAM,supra note 14, at 89.
60. See T.V. Padma, Digital Library to Protect Indigenous Knowledge (Jan. 10,2005), http:I/ww w.
scidev.net/en/news/digital-library-to-protect-indigenous-knowledge.html.
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II. CHINA AND TAIWAN:
OF MIXED SIGNALS AND CREATIVE LEGAL INTERVENTION
A. China: A Case of Mixed Signals
Like India, China is a global leader in traditional medicinal practices. China's
rich traditional medicinal heritage has a complicated history.6' A substantial part
of Traditional Chinese Medicine (TCM) is based on rational theoretical principles
which are also codified in several Chinese medical classics.62 TCM has often been
distinguished from the medical traditions of Chinese national minorities such as
those of Tibet and Mongolia.63 A combination of factors, including its deep theo-
retical foundation, secular nature, and codified status, tends to distinguish TCM
from other forms of indigenous, folk, or traditional medical systems.64 China does
not seem to have developed a keen interest in the documentation of its rich TCM,
which also flourishes in the rest of East Asia, including Hong Kong, Taiwan,
Japan, and the Koreas. In comparison to other traditional medical systems, TCM
is reasonably integrated with conventional medicine, this being facilitated by its
rationalism, among other considerations. Indeed, the pursuit of integration with
conventional medicine, including the latter's scientific techniques, is the focus of
TCM in contemporary times. In 2004, the Chinese government embarked on an
aggressive system of"scientification" of TCM along the patterns of the integration
strategy. That year,
the Chinese Ministry of Science and Technology . . . made the
modernization of [traditional medicines (TM)] one of the 12 main
61. See OGUAMANAM,Supra note 14, at 121; Wang Pei, Traditional Chinese Medicine, in TRADITIONAL
MEDICINE AND HEALTH CARE COVERAGE 68,68-75 (Robert H. Bannerman et al. eds., 1983).
62. The U.S. National Library of Medicine (NLM), which is part of the National Institutes of
Health (NIH), has an online exhibit of the Classics of Traditional Chinese Medicine. For a sample of
this rich resource, see http://www.nlm.nih.gov/hmd/chinese/books.html (last visited May 21, 2008).
63. For instance, Taiwan's Draft CHM Invention Patent Guideline does not include Tibetan
and Mongolian traditional medicine as part of TCM. See Draft CHM Invention Patent Guideline
(2002), available at http://www.tipo.gov.tw/patent/patent-law/examine/patent-law-3.asp [here-
inafter Draft Guideline].
64. See OGUAMANAM, supra note 14, at 121 (referring to the sophistication of TCM as docu-
mented since the Zhou dynasty and broadly delivered in four departments of medical specialty,
namely nutrition, internal medicine, surgery and veterinary medicine); Ralph C. Croizer, Medi-
cine, Modernization and Cultural Crisis in India and China, 12 COMP. STUD. Soc'Y & HiST. 275,
275-91 (1970).
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focal points of its current 5-year plan. An entire technology park in
Houzhou has been devoted to the scientific study of Chinese medi-
cine. Most of the investment occurs in state institutions. Much of
the impetus arises from fears that foreign pharmaceuticals will
dominate the Chinese market.65
Despite being driven by philosophies and theories, TCM's "traditional knowl-
edge content is not easy to define."66 As TCM increasingly gets integrated with
Western medicine, associated traditional and indigenous knowledge practices are
sidelined as they become less of a priority. Indeed, recent legislative interventions
in TCM in China do not address its traditional knowledge component in any
specific way.67 Rather, individuals or corporations are positioned as recognized
claimants to intellectual property rights in TCM.6 Thus, one logical consequence
of integration of TCM with Western scientific medical techniques is China's em-
brace of patents as a viable protection regime for TCM.
Although there has been little regulation of TCM in China until fairly re-
cently, the protection of TCM is not limited to the pursuit of its integration with
Western scientific medicine. Rather, China sends a mixed signal reflecting, to a
certain degree, a dialectical approach to intellectual property (patent) in the con-
text of TCM. For example, the 1992 substantive law on the protection of Tradi-
tional Chinese Medicines 69 places emphasis on research and development (R&D)
of innovations in the field of TCM, and adopts language suggestive of a Western-
style scientific standard of validation for TCM.7° Because "[t]he law is not appli-
cable after patent rights have been applied for," the Chinese protection of TCM
has been described as "a sui generis system designed to operate in conjunction with
patents. '7' The law's focus on R&D appears to facilitate recent innovations on
TCM as a prelude to their uptake into the conventional patent system, an impor-
tant step in bolstering the integration of TCM into the Western scientific system.
65. Eilandsupra note 39, at 78-79.
66. Id. at 79.
67. See China's Regulation on the Protection of Traditional Chinese Medicine (1992), http://
cq.netsh.com/bbs/751605/html/tree_5837217.html [hereinafter Regulation].
68. Eiland,supra note 39, at 77.
69. See Regulation, supra note 67.
70. For example, the regulation makes reference to the protection of "stable" forms of TCM
which is suggestive of "scientific replicability." Regulation, supra note 67, art. 3. See also Eiland,
supra note 39, at 77.
71. Eiland,supra note 39, at 77.
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From all indications, China's head start in the integration project of its TCM
with Western scientific medicine, supported by its extraordinary human and
techno-scientific resource base for the project, makes patenting an attractive op-
tion for that country's ultimate objective to protect its traditional medical knowl-
edge and practices. China is a major player in the global economy, and a
formidable competitor with little to fear and much to gain from bringing its rich
TCM into the global market place. It would seem then that the concern about
biopiracy does not have the same resonance in China as in India and the South
East Asian countries, and in most of the developing world. In its global dispersal,
transformations, and continued integration with conventional medicine, TCM is
a showcase for cultural cosmopolitanism.
China's lack of enthusiasm about the establishment of a database for its TCM
and its apparent favoring of a direct patent and so-called sui generis protection
model is explained by a number of other reasons. First, the current level of protec-
tion of TCM under the patent regime, and advances in TCM's integration with
conventional medicine, make the idea of a database fairly unattractive to China.72
Second, China, Korea, and Japan have a partially shared history regarding the
development of traditional medicine." Thus, for the purpose of documentation,
language may become a key obstacle. The same formula used for traditional
medicine in each of these countries may be articulated via differentiated linguistic
and philosophical expression and emphases.7 4 To this end, Eiland observes that:
It is difficult to communicate precise information about some aspects
of TM given this level of uncertainty. The titles of TCM as expressed
in Chinese characters have an ideographic meaning as distinct from
a phonetic one as in an alphabetic system. When Chinese characters
are translated into English directly-without explanation-a scien-
tist would not understand their meaning. Many words indicate not
only specific herbal materials and effectiveness but also expressions
familiar only to Chinese culture. The problem is particularly acute
with remedies involving multi-herb formulations."
With regard to herbal formulations, CHM is a subset of TCM, and perhaps
72. Id. at 79.
73. Id.
74. Id.
75. Id.
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the most prominent, given that herbs account for over 80 percent of TCM formu-
lations and practices.7 6 Along with other forms of CAM, CHM has gained much
global popularity, and enjoys prominent visibility and patronage in the Western
world. 7  The U.S. Food and Drug Administration (FDA) has indicated its inten-
tion to recognize the marketing of botanicals as prescription drugs.78 This is al-
ready the case in a number of countries, including Japan and Germany. In addition
to its acceptability in the centers of global financial capital in the West, the poten-
tial leap of herbal medicine from natural food products or naturaceuticals in the
United States, to prescription drugs and other possibilities, continue to fuel the
market for the botanical industry and CHMs from South Asia, especially Tai-
wan.79 In fact, Taiwan ranks third to Japan and Germany for R&D, manufactur-
ing, and quality control of herbal medicines.80
The Western scientific approach to phytomedicine (i.e., drug development
based on herbs) involves, for the most part, the isolation or production from plants
of bioactive compounds having new or known structures to serve as drugs or lead
compounds for drugs. It also involves the use of bioactive agents from plants as
pharmacological tools, and the use of an entire plant or part thereof as herbal
medicine. Without a doubt, phytomedicine is a universal approach to drug discov-
76. The centrality of herbs in TCM is not a phenomenon peculiar to that system of medicine.
Indeed, it seems to be the case with virtually all non-conventional medical traditions. See OGUA-
MANAM,supra note 14, at 118-26 (providing an analysis of the role of herbs in traditional medicine).
See generally MEDICINAL PLANTS: THEIR ROLE IN HEALTH AND BIODIVERSITY (Timothy R. Thom-
linson & Olayiwola Akerele eds., 1998) [hereinafter MEDICINAL PLANTS] (a collection of articles
discussing the role of medicinal plants).
77. In many developed countries, CAM is becoming more popular. For example, the percentage
of the population that has used CAM (which includes TCM) at least once is 78 percent in France,
70 percent in Canada, 48 percent in Australia, 42 percent in the United States, and 38 percent in
Belgium. See WORLD HEALTH ORGANIZATION, TRADITIONAL MEDICINE STRATEGY 2002-2005 1-2
(2002). See also D.M. Eisenberg et al., Unconventional Medicine in the United States: Prevalence,
Costs and Patterns of Use, 328 NEW ENG. J. MED. 246,246-52 (1993); Edzard Ernst, Prevalence of Use
of Complementary/Alternative Medicine: A Systematic Review, 78 BULL. OF THE WORLD HEALTH
ORG. 252, 252-57 (2000).
78. See U.S. FOOD AND DRUG ADMINISTRATION ET AL., GUIDANCE FOR INDUSTRY BOTANICAL DRUG
PRODUCTS (2004), available at http://www.fda.gov/cder/Guidance/4592fnl.pdf; Dennis Normile,
The New Face of Traditional Chinese Medicine, 299 SCI. MAC. 188, 188 (2003), available at www.
sciencemag.org.
79. See Hsiao, supra note 25, at 2.
80. Id.
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ery in virtually all cultures and civilizations, even though the methodology of
discovery may vary in detail.8
For patenting purposes, the Western scientific approach to phytomedicine is
readily privileged. As noted above, that approach concentrates on the isolation of
core or single chemical compound(s) and their association with biological activi-
ties that are relevant to clinical application. More than this, it is able to purify the
compounds or structurally modify or synthesize them so as to remove the result-
ing invention from the "realm of nature" and discovery into the patentable mod-
ule.8' Under this practice, there is little mixing of herbs or plants and plant parts.
For the most part, the combination or mixture involves known compounds. In
contrast, CHM handles compounds that are not pure. Most of the inventions re-
late to plants, plant parts, and their diverse mixtures or combinations, resulting in
complex formulations.83 Also, as already noted, CHM is theory-driven. Leading
producers of herbal drugs, such as Japan and Germany, pursue a strictly scientific
approach to herbal medicine; they strip it of any theoretical foundation and trans-
form it into a context-neutral exercise.
For example, Japan's adaptation of TCM, the Kampo, which dates back to be-
tween the fifth and seventh centuries, owes its identity to the filtration or separation
of underlying TCM theories. 4 Japan is one the first countries in the world to take a
strictly scientific approach to TCM, ridding it of its theories and pragmatically re-
taining the herbal knowledge in its scientific form.85 Following a checkered history
81. See OGUAMANAM supra note 14, at 118-26; Hubertus Cranz, Medical Plants and Phytomedi-
cines within the European Community, in MEDICINAL PLANTS, supra note 76, at 194-95; Robert G.
Pinco, The Evolving Status of Herbals and Phytomedicines in the United States, in MEDICINAL PLANTS,
supra note 76, at 198-204.
82. See Agrawal,supra note 7, at 179; Chidi Oguamanam, The Convention on Biological Diversity
and Intellectual Property Rights: The Challenge of Indigenous Knowledge, 7 S. CROSS U. L. REV. 89
(2003). See generally Yano,supra note 7 (discussing the longstanding prohibition in the U.S. patent
case law against the patenting of "products of nature").
83. In other domains of CAM outside of the CHM module, complex cultural rituals or ceremonies,
observations and practices are part of the traditional medicinal intervention. According to Native
American scholars Batiste and Henderson, while the Western scientific model of intervention may
understand the application of a native herb, it may not produce a curative outcome without the accom-
panying ceremony, ritual songs or chant, and prayers. See MARiE BArrISTE & J. (SA'K'Ej) YOUNGBLOOD
HENDERSON, PROTECTING INDIGENOUS KNOWLEDGE AND HERITAGE: A GLOBAL CHALLENGE 43 (2000).
84. See Katsutoshi Terasawa, Evidence-Based Reconstruction of Kampo Medicine: Part I-Is
Kampo CAM?, in EVIDENCE BASED COMPLEMENTARY ANi ALTERNATiVE MEDICINE 11, 13-16 (2004),
available at http://ecam.oxfordjournals.org/cgi/reprint/l/l/ 1.
85. Id. at 14 (noting that the "Japanese paradigm of Kampo is little dependent on, if not free
from, the Yin-Yang/Five Elements paradigm [of TCM] ... [and I can be characterized as a simpli-
fied, positivistic and pragmatic version of Chinese herbal medicine").
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that parallels historic transformations in Japanese society, Kampo medicine has
been fully entrenched in the curriculum of Japanese medical and pharmaceutical
education and in its health care delivery. In this regard, Katsutoshi Terasawa notes
"[a]fter their official recognition as medical drugs, chemical and pharmacological
research on Kampo herbs has made dramatic progress in Japan. The chemical com-
ponents of each herb are now analyzed in such detail that I think we can now safely
talk about the new science of Kampo as the science of complex, or compound
drug."6 According to Hsiao, "more than 70% of the doctors in Japan who were
trained under the Western medical system prescribe Kampo extraction. Kampo ex-
tractions in Japan were studied scientifically for their single compound as well as for
the safety and efficacy of [their] formulas."87
The success of Japan and Germany as leading global suppliers of herbal and
botanical drugs can be attributed, at least partially, to their strict scientific ap-
proach to the manufacturing process."8 The "success model indicates the accep-
tance of Western drug-like herbal medicines in the main pharmaceutical markets
today."8 9 One other reason for this success is that the scientific approach easily
makes herbal medicine amenable to patent protection. Consequently, the scien-
tific approach assures herbal medicine's acceptability and legitimacy. Its global
acceptability becomes a source of economic empowerment for those countries that
follow the scientific model. For countries such as Japan and to some extent, China,
one way to address the logjam arising from the failure of the patent system to ac-
commodate traditional medicine and the resultant marginalization of non-West-
ern knowledge forms is to strip herbal medicine of its local knowledge and
theoretical content. That way, its complete integration with, or uptake by, West-
ern scientific medicine becomesfait accompli.9° Because it does not focus on the
local knowledge content of herbal medicinal and associated theories, this ap-
86. Id. at 15-16.
87. Hsiao, supra note 25, at 6 (citations omitted). But see Terasawa, supra note 84, at 13 (propos-
ing that the effects of Kampo medicines fall into a "multiple-interacting components paradigm").
88. The Japanese medical tradition has a historical relationship with the Dutch system. Yam-
awaki, one of the leading Kampo physicians, was a critic of the Chinese understanding of human
anatomy. His significant influence assured a unique identity for Kampo. His time marked an im-
portant period that emboldened Japanese physicians to introduce Western medicine "through the
Dutch, who were the only Westerners officially permitted to trade with Japan." See Terasawa,supra
note 84, at 14.
89. Hsiao, supra note 25, at 6.
90. Terasawa, supra note 84, at 13 (noting that Kampo medicine's complacency with being a
local standard should not be tolerated: "Kampo should not and cannot avoid meeting the chal-
lenge of the evidence-based medicine of the West").
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proach does not problematize or magnify the troubled relationship between the
conventional patent system and indigenous or local knowledge.
By deliberately positioning its traditional medicinal practices in Western sci-
entific ontology, China's commitment to the protection of TCM, including CHM,
via the conventional patent system is unequivocal. When TCM is supported and
empowered through the interaction of the scientific and legal frameworks, it is
then easy to analogize it to Western biomedicine. Under this approach, it is diffi-
cult for the advocates of TCM to problematize intellectual property as is the trend
by other proponents of local knowledge.
Unlike the marked shift in Japanese Kampo rendition, China strictly holds
on to the theoretical and philosophical orientation of its medical traditions, which
is located within the broader CAM. In practice and as a process, the latter is an
epistemological alternative to Western biomedicine. Thus, in regard to the protec-
tion of its TCM, China maintains a dialectical and simultaneously ambivalent
relationship with the patent system. It sends a mixed signal by aggressively en-
trenching TCM into the Western scientific medical ontology and conventional
intellectual property system while, at the same time, capitalizing on TCM's deep
theoretical roots as an alternative to Western biomedicine. The divide between
CHM and Western scientific medicine has been abridged differently in Taiwan,
through creative regulatory intervention.
B. Taiwan: Creative Legal Intervention
Recent developments in Taiwan show a willingness to consolidate or improve
its status as the world's third largest producer of herbal medicine. Like Japan, Tai-
wan is sure-footed in a strict scientific approach to CHM. However, Taiwan realizes
that although that approach makes for successful patent applications, it does not ac-
commodate the theoretical and traditional knowledge content of TCM. Taiwan
seeks a revision of its patent regime to accommodate a theoretical approach to TCM
and to recognize TCM's emphasis on the combination of complex plant formula-
tions as opposed to the focus of Western scientific methods on single or core chemi-
cal compounds as constituting the raw compounds for producing herbal drugs. In
2002, Taiwan proposed a Draft CHM Invention Patent Guideline, which aims to
plug the loopholes in its extant patent law, in view of the difficulties associated with
the patentability of CHM in its theoretical coloration.9'
91. See generally Draft Guideline, supra note 63. The debate continues regarding its finalization
and adoption.
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Perhaps the most significant aspect of CHM theory is that it represents an
alternative epistemic approach to that which underlies Western scientific medical
knowledge and understanding.9 2 CHM has been described as the "crystallization
of Chinese people's wisdom and experience. ' This collective knowledge pool has
a bearing on the way herbs are used for drugs, and on overall therapeutic inter-
vention in health service delivery. The components of, and insights into, the op-
erational mechanism of the Chinese medical tradition are informed by specific
elements of its theoretical construct. This construct includes concepts such as Qi,
Ying-Yang, and Meridian, as well as the process of prescription of herbal formulas,
the practice of acupuncture, moxibustion, etc.94
As mentioned earlier, Western scientific medicine adopts Cartesian reduc-
tionism, separating the body and the mind.9" It also adopts a targeted approach to
therapeutic intervention. In terms of the use of herbs for drug production (phyto-
medicine), this model concentrates on isolating single or core chemical compounds
from plants. Western medicine adopts a corresponding therapeutic intervention
that aims to "identify a particular chemical, hormonal or biological imbalance
and to treat the symptom with a counteracting medicine (normally a bioactive
compound directed to a well-defined disease [and organ] target). 19 6 In contrast,
CHM, like other non-conventional or traditional medicinal systems, adopts a ho-
listic approach that encapsulates Chinese philosophical worldview and reflects the
nature of human interaction with natural forces.97
In a nutshell, a successful therapeutic intervention via CHM results from the
attainment of equilibrium or balance in the human body. This is depicted as Ying
and Yang, which correspond to parts of the body (substance of body cells and chem-
icals) and the energy or forces that activate the body cells. The major raw materials
for CHM are plants, and to some degree animals and minerals. CHM involves the
characterization of various properties of different plants under four drug essences,
92. See OGUAMANAM,SUpra note 14, at 121-22.
93. See Pei, supra note 61, at 68.
94. See OGUAMANAM,supra note 14, at 102-103; Barbara Avery & Rocky Avery, Oriental Healing:
The Ying-Yang Concept, in FOLK MEDICINE AND HERBAL HEALINC 139, 139-65 (George G. Meyer et
al. eds., 1981); Pei,supra note 61, at 68.
95. See Hsiao, supra note 25, at 4.
96. Id. See also Oguamanam,supra note 26, at 96-97.
97. Hsiao, supra note 25, at 4. But see DAVID PHILLIPS, HEALTH AND HEALTH CARE IN THE THIRD
WORLD 80-83 (D.J. Dwyer ed., 1990) (arguing that the holistic construct of traditional medicine
may be overstretched, does not necessarily hold true in all cases, and could create a misleading
impression of traditional medicine's efficiency and limits).
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namely, cold/cool drugs for tackling Yang, and warm/hot drugs for Ying diseases.98
In addition to these four essences, CHM's theoretical outlook includes five flavors,99
four directions,"' and seven effects.' In terms of prescription or delivery, CHM is
administered in two formulations, either as single applications comprising one
herbal preparation (Dan Xing) for the treatment of acute conditions, or a complex
combination or mixture of various herbs (Fu Fang) for treating chronic diseases.
Because of its focus on one herbal preparation, Dan Xing is closer to Western scien-
tific medicine than Fu Fang, which enjoys greater preeminence in CHM.
Taiwan's new and pending initiative for the calibration of its patent regime to
accommodate TCM tackles the subsuming of Fu Fang under the extant patent
system. Because of the patent regime's focus on a strict scientific approach to
herbal medicine and the recognition of single or core active substances with thera-
peutic consequences, herbal drug development in Taiwan under TCM is, for the
most part, limited to Dan Xing.'°2
The diagnostic process that precedes the administration of CHM involves the
identification of a patient's Zeng, or biochemical profile or data, through a number
of strategies, including "observation, listening, questioning and palpation accord-
ing to TCM theory."'0 3 Identification of Zeng is followed by:
prescription of herbal formulas [which] use TCM theory to balance
the different effects of the plants, eliminate toxicity and enhance
efficacy. This is the process by which herbal formulas can achieve
their effects as recorded in the classics; the pharmacological effects
and the harmless combination of herbs are through the correct ap-
plication of TCM theory and not because natural products are in-
deed safe and non-toxic. 4
TCM's emphasis on a complex combination and interaction of various herbs
and underlying theories that gird their prescription and use make the identifica-
tion of active ingredients in plants not only difficult but also of trivial essence. At
98. See Hsiao, supra note 25, at 5. See generally Barbara Avery & Rock Avery, supra note 94, at
139-65.
99. Pungent, sour, sweet, bitter, and salty. Hsiao, supra note 25, at 5.
100. Ascending, floating, descending, and sinking. Id.
101. Single, additive, synergic, antagonistic, inhibitive, destructive and opposite. Id.
102. See Id.
103. Id.
104. Id.
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the same time, the combination of herbs and their interactions are yet to receive
any serious consideration in Western scientific approaches to herbal medicine, °5
nor are they accounted for by the conventional patent system. Key aspects of
TCM's challenge to the patent regime, which the 2002 Taiwan Draft CHM In-
vention Patent Guidelines propose to tackle,'0 6 include:
(a) Confusion in the naming of plants in the different TCM classics,
which tends to become problematic for patent purposes when a CHM inven-
tion does not involve a pure compound. In this case, the Draft prescribes dif-
ferent approaches to be followed to achieve taxonomic uniformity and to
mitigate inconsistency in the classical nomenclature.' 7
(b) The difficulty with identifying active ingredients in crude materials
used in TCM for the purpose of TCM patent examination. The Draft makes
a bold attempt to recognize the differences in plant characteristics due to the
environments of their cultivation or the circumstances of their harvest. It also
provides for accommodation of information in a TCM patent specification
dealing with the therapeutic functions of different parts of the same plant
where applicable. 0
(c) The nature of plants and plant varieties as living organisms which, of
necessity, have variable characteristics, in contrast to chemical compounds
which can be reproduced at an industrial scale of uniformity and stability. To
this end, the Draft further recognizes four types of CHM patents. The first is
combination preparation, referring to a combination of plants or parts thereof.
Thus, in place of identification of active ingredients, identification of the
plants used in the combination will suffice. Perhaps most importantly, a
CHM patent based on a combination preparation that cannot be listed by
chemical composition can be defined via product-by-process, while limiting
the patent claim to only the product.' 9 The second type is patents based on
105. Id. (stating that it is a popular, but false belief that CHM are medicines solely for chronic and
minor diseases). See also Terasawa, supra note 84, at 13 (stating that the linear cause-effect ap-
proach to chemical remedies, which is the hallmark of Western medicine, "is now being chal-
lenged, even within the realms of Western science").
106. The original or official language of the Draft Guideline is Mandarin. Page references to the
Draft Guideline appear as they appear in the original document. Due to the absence of an official
English translation, this section draws from Hsiao's elaboration of the Draft Guideline. See Hsiao,
supra note 25, at 14-15 (identifying the critical issues addressed by the Draft Guideline).
107. See Draft Guideline, supra note 63, at 28-29; Hsiao,supra note 25, at 14.
108. Id.
109. For a detailed analysis of the four categories of CHM product patents, see Hsiao,supra note
25, at 14.
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CHM extracts and purified plant parts. Here, it suffices if only the principal
active ingredients are identified and not necessarily each individual active in-
gredient. Again, where the active ingredients cannot be listed or represented
by chemical names and structures, they can be defined by way of product-by-
process. " ' The third CHM patent type is the CHM Active Compound, which
applies where the compounds extracted from plants have been successfully
purified. This fits within the Western scientific standard for phytomedicinal
drug discovery."' The last type is the CHM Delivery System which relates to
CHM administration, dosage, etc. This category provides perhaps the most
proactive uptake of CHM theory under the proposed patent system in Tai-
wan. 112 It specifically requires patent specifications to include information on
the treatment of Zeng, the raw materials applied, as well as the TCM theory
deployed in establishing the efficacy of the invention. Where an invention
targets a disease outside TCM ("Western disease"), it must be scrutinized for
efficacy under Western pharmacology."3
(d) The prevalence of impure substances in plants and the problem as-
sociated with establishing CHM's pharmacological efficacy. The Draft pro-
vides for difficult cases where an extract from a part of a particular plant
might have a different medicinal value from the one already associated with
the main plant in the treatment of a Zeng. A person having ordinary skill in
the art (PHOSITA) cannot associate this with codified TCM. As a way out,
the Draft provides for the inventor to specifically prove or disclose the efficacy
of this CHM invention or to supply references in the specification to buttress
the invention's efficacy. Again if the TCM invention targets a disease not
known to TCM ("Western disease"), its efficacy will require Western phar-
macological scrutiny."'
Although the Draft TCM Invention Patent Guideline is still being debated and
is yet to come into force, the initiative is significant in a number of respects. First, it
is symbolic of the legal creativity required of developing countries to demonstrate
that the Agreement on Trade-Related Aspects of Intellectual Property Rights
(TRIPS) did not completely obliterate the status of intellectual property as subject-
matter of national law. However, if and when the Draft is adopted, there may be a
110. Id.
11. Id.
112. See Draft Guideline, supra note 63, at 32-39; Hsiao,supra note 25, at 15.
113. Hsiao, supra note 25, at 15.
114. Id.
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reasonable basis to challenge it on grounds of lack of compatibility with TRIPS."'
Second, the Taiwanese initiative exposes subtle but significant differences in the
priorities of developing countries in regard to securing their individual interests
under the patent system. Indeed, these differences drive country-specific strategies
for engaging with the intellectual property system. Third, Taiwan's initiative repre-
sents the first time any country has proffered a legal remedy for the epistemic schism
between traditional medicine and Western scientific medicine via the patent sys-
tem."' Fourth, the initiative is indicative of the potential for the co-existence of tra-
ditional and Western scientific medicine, albeit in the context of drug development
and, to some extent, therapeutic intervention under a single intellectual property
framework. Thus, the initiative has a potentially positive implication for the institu-
tionalization of medical pluralism in the long run.
Fifth, and perhaps most important, the integration of TCM in its theoretical
construct with its strict atheoretical or Western scientific transformation under one
legal framework is a powerful representation of the reality of cultural cosmopolitan-
ism. Not only does the Draft affirm the epistemic identities of Western scientific
medicine and CHM, it also acknowledges the reality of their interaction and meld-
ing. Sixth, in relation to the Indian-championed documentation of traditional me-
dicinal knowledge, Taiwan's TCM Invention Patent Guideline is a more direct
attempt to introduce the theoretical core of traditional medicine (CHM) into the
intellectual property (patent) system with which its has continued to have a frosty
relationship. Seventh, Taiwan's proposal for the accommodation of the theoretical
essence of CHM in its patent system is significant for many indigenous and local
communities and, certainly, the rest of the developing countries. The latter's current
efforts concentrate on an anti-appropriation strategy which they seek to implement
against biopiracy. The anti-appropriation strategy is symbolized in the TKDL proj-
ect, which essentially constitutes a means to an end and, arguably, in some way, the
end itself. The more desirable end appears to be the empowerment of indigenous
and local knowledge under the extant or new legal framework. Taiwan's initiative
indicates this objective can be explored via an inward looking, cost-effective creative
115. It is merely within the realm of conjecture whether the Draft Guideline constitutes a technol-
ogy-specific discrimination, which the TRIPS Agreement does not sanction. My preliminary under-
standing is that this Draft Guideline is compatible with TRIPS to the extent that it opens traditional
medicine up to patentability-a development that is consistent with the spirit and letter of TRI PS in
regard to bringing all technologies under the realm of patent protection. Indeed, since TRIPS is a
foundation without a ceiling, counterintuitively, this initiative is a form of"TRIPS-plus."
116. See generally Oguamanam,supra note 26 (reviewing the patent-empowered epistemic schism
that thwarts the protection of traditional medicine in international law and public health policy).
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strategy which potentially has ramifications for the rest of the developing world. It is
instructive that Taiwan's strategy is being pursued via a patent examination guide-
line and not by means of a brand new piece of patent legislation."7
In sum, the Taiwanese initiative demonstrates that TRIPS did not completely
obliterate the national character of intellectual property lawmaking. It shows that
through creative legal interventions, states can devise intellectual property strategies
that cater to their national experience and uphold their aspirations for rethinking
the conceptual framework of the patent system in regard to traditional knowledge.
III. DISCLOSURE OF ORIGINS AND GEOGRAPHICAL INDICATIONS
The third major development in the attempt to bridge the gap between the
conventional patent system and traditional knowledge is disclosure of origins (DRs)
and geographical indications (GIs)."' This last category does not directly apply to
traditional medicine per se. In comparison to the first two examples, the signifi-
cance of DRs and GIs is perhaps marginal, both in terms of their approach and
impact on mitigating the patent system's disdain for traditional knowledge. None-
theless, recent steam around DRs and GIs lends credence to the thesis of cultural
cosmopolitanism. DRs and GIs reflect the interconnectedness and interdependence
of knowledge systems and the global reach and exchange of locally susceptible cul-
tural products. DRs and GIs add pressure to the intellectual property system at na-
tional and global levels for creative re-examination of the patent system's conceptual
framework in terms of having to accommodate traditional knowledge.
A. Disclosure of Origins
Like the traditional knowledge database, DRs are an anti-appropriation strat-
egy which could ensure some accountability in the use of traditional knowledge in
117. Taiwan's resort to the Draft Guideline is cost-effective. It also underscores the significance
of subsidiary rules and regulations to the administration of intellectual property rights. Often,
there is a significant disparity between the substantive provisions of a patent statute and its associ-
ated guidelines. In terms of patents, like all things, the devil resides in the details and these are
usually elaborated in the guidelines.
118. For a general review of the concept of DRs and GIs, see Emanuela Arezzo, Struggling Around
the Natural Divide: The Protection of Tangible and Intangible Indigenous Property, 25 CARDOZO ARTS &
ENT. L.J. 367 (2007); Irene Calboli, Expanding the Protection of Geographical Indications of Origin
Under TRIPS: Old Debate or New Opportunity?, 10 MARQ. INTELL. PROP. L. REV. 181 (2006); S.K.
Soam, Analysis of Prospective Geographical Indications in India, 8 ). WORLD INTELL. PROP. 679 (2005),
available at http://www.blackwell-synergy.com/doi/pdf/I0. Ill I/j.1747-1796.2005.tb00274.x.
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patent applications. In addition, DRs, which derive their impetus principally from
the 2000 Bonn Guidelines on Access to Genetic Resources and Fair and Equitable
Sharing of the Benefits Arising out of their Utilization, 9 are a non-mandatory
strategy aimed at enhancing the determination of prior art and the facilitation of
efficient monitoring of prior informed consent (PIC) and access and benefit sharing
(ABS), especially as elaborated under the Convention on Biological Diversity
(CBD) 2° Subject to variation in detail, under DRs, patent applications for inven-
tions relating to genetic resources are required to disclose the "sources" or "origin" of
the genetic material and/or associated traditional knowledge. Because plant and
animal materials form a significant aspect of traditional medicine, the limitation of
DRs to patent applications involving genetic resources directly draws attention to
the nexus between traditional medicine and the patent system.
Strong opposition and skepticism have trailed DRs, the exploration of which,
though desirable, is outside the framework and scope of this article. Opposition is
grounded in a number of reasons, including non-feasibility, cost and effectiveness
of monitoring the origins and uses of genetic resources, and the technical distinc-
tion between "source" and "origin."'2' Another objection relates to the nature of
traditional knowledge and the difficulties associated with determining its appli-
cation with any accuracy in the patent context. Then, reservation attaches to the
identification of the origin of both genetic resources and associated traditional
knowledge, especially where there is a disagreement in regard to the details and
application of such knowledge between original and subsequent claimants. Also
of concern is the appropriateness of using the patent system, which is primarily
designed to advance innovation, and to mitigate concerns about equity and benefit
sharing.'12 Related to this are fears of uncertainty and the potential of a DR re-
quirement to "overload" an already troubled patent system by further complicat-
119. The Draft Guideline was approved pursuant to Decision V1/24 of the 2002 Conference of
Parties (COP) Meeting of the CBD, available at http://cbd.int/decisions/default.asp?m=COP-
06&id=7198&lg=0>.
120. Convention on Biological Diversity, June 5, 1992, 31 I.L.M. 818.
121. There is no strict correlation between the traditional origin of a particular genetic material
and its present source even though the undergirding knowledge and application may be the same.
As an example, over time, second comers may sponsor the cultivation of a genetic resource ex situ,
creating a more viable source for it which is different from its historic or traditional origin. Also,
migration patterns, ecological dynamics and other environmental factors can fuel disparity be-
tween the origin and subsequent source of genetic material.
122. For a critical appraisal of the DRs, see Alison Hoare & Richard Tarasofsky, Asking and Tell-
ing: Can Disclosure of Origin Requirements in Patent Applications Make a Difference?, 10 J. WORLD
INTELL. PROP. 149 (2007).
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ing the question of patentability.' 23 Lastly, the politics of DRs is fast becoming
complicated: it began by pitting transnational corporate interests in the developed
world against rural communities and developing countries. Now, as Alison Hoare
and Richard Tarasofsky note, the "burgeoning biotechnology industry in many
developing and biodiverse countries ... Imeans] the lines between provider and
user countries are becoming increasingly blurred, and the debates [on DRs] ...
are more nuanced than is often suggested." 24
Despite the reservations about DRs, in the less than ten years since disclosure of
origin entered the policy discourse on the intersection of traditional knowledge, in-
tellectual property, and access and benefit sharing, it has in some cases become en-
trenched as part of national law. Certainly, DRs are an important subject in the
ongoing policy discussions in key international forums, including the CBD, WIPO
Intergovernmental Committee on Genetic Resources, Traditional Knowledge and
Folklore (IGC), World Trade Organization (WTO), and regional trade and intel-
lectual property organizations. 21 For instance, following the 1998 European Com-
mission (EC) Biotechnology Directive, 126 a number of European Union countries
enacted national laws that incorporate DRs. 27 Notwithstanding variations in the
details of country-specific regimes on DRs in these European countries, provisions
of the legislation highlight tacit acknowledgement of gaps in the conventional patent
system, 2 ' the imperative for transparency, and the need to restore the integrity of
that system. In addition to national initiatives in Europe, the incorporation of DRs
into multilateral intellectual property administrative and regulatory cooperatives,
such as the Patent Cooperation Treaty (PCT) and the Patent Law Treaty (PLT), is
currently being elaborated in these forums.'29 In developing countries, regional
bodies such as the Andean Pact, the African Union, and the Pacific Forum have,
123. Id. at 150. See also Arezzo,supra note 118, at 387.
124. Hoare & Tarasofsky,supra note 122, at 159.
125. For a detailed elaboration of the debates about DRs, see Arezzo,supra note 118, at 393-98.
126. See Council Directive 98/44/EC, 27, 1998 O.J. (L213) 13, 15 (EC).
127. For example, Belgium, Denmark, Germany, and Sweden. Also Norway and Switzerland
have reached advanced stages in the introduction of DR provisions in their patent regimes.
128. It needs mentioning that fair access and equitable benefit, as well as regard for the use of
traditional knowledge in an invention, did not motivate the introduction of DR regimes in the
European countries. See Hoare & Tarasofsky, supra note 122, at 154. Further, in these countries,
DRs are either optional, or when they are required, there is no sanction attached to non-disclosure.
Nonetheless, DR provisions assist in tracing its use and in the determination of prior art.
129. See Arezzo,supra note 118, at 380-82.
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since the early 2000s, adopted common legislative frameworks supportive of PIC,
ABS, and DRs among their member states.'
In addition to regional initiatives, developments are taking place at the na-
tional level. Many developing countries have adopted or amended laws to provide
for divergent national regimes incorporating PIC, ABS, and DR requirements.
Examples of those countries include Brazil, Costa Rica, Egypt, India, the Philip-
pines, and Venezuela. 3' These countries, especially Brazil, India, and Venezuela,
along with Thailand, Cuba, and others, support amending the patent provisions
of the TRIPS Agreement to accommodate DRs. They also endorse the creation
of a sanction and enforcement regime akin or pursuant to the WTO dispute set-
tlement and enforcement mechanisms for non-compliance with DRs."'
From this parsimonious overview, it is obvious that the scope of implementa-
tion and ongoing discussion regarding DRs are quite widespread across relevant
national, international, and regional patent forums. Despite reservations about
the long-term feasibility of DRs, there is little doubt, thus far, that proponents of
the concept are able to elicit a response in the conventional patent system that is
open to grappling with the reality of traditional knowledge. Like the results of
the TKDL project explored in Part I, this shift marks a significant departure
from helpless reliance on the traditional excuse that intellectual property rights
are hopelessly irreconcilable with traditional knowledge.
Without a doubt, for holders of traditional knowledge, DRs, like the digital
library project, are not necessarily or conclusively an end in themselves. They are
a site for negotiating some form of temporary compromise between the patent
system and traditional knowledge. Perhaps the importance of DRs lies more in
their potential to open up the patent system to the demands of traditional knowl-
130. The 1996 Andean Pact (Bolivia, Colombia, Ecuador and Peru), Decision 391 on Common
Regime on Access to Genetic Resources was the precursor to the 2002 Decision 486 which directly
provides for DRs. The African Model Legislation for the Protection of the Rights of Local Com-
munities, Farmers and Breeders and Regulation of Access to Biological Resources-an initiative that
started in 1997 and was formally adopted in 2000 by the African Union, among other things, aims at
proving a framework for access to Africa's rich biological resources, associated traditional knowledge
in accordance the principles of PIC and ABS which provide a compelling basis for national DRs re-
gimes. See Grain, Biodiversity Rights Legislation (BRL), Nov. 17, 2007, http://www.grain.org/brl/.
131. See Hoare & Tarasofsky, supra note 122, at 156. See also Arezzo, supra note 118, at 382. See
generally Grain, supra note 130 (containing a database of"biodiversity rights legislation" which "is
a collection of emerging laws that directly affect people's control over agricultural biodiversity in
developing countries. It compiles those legislative texts that define rights in relation to genetic re-
sources or to the knowledge associated with those materials. They may be rights of ownership,
intellectual property, stewardship, access, sovereignty or something else").
132. Arezzo, supra note 118, at 382-83.
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edge for recognition in its own right, and the urgent need for a meaningful en-
gagement between traditional knowledge and the patent system, than with the
feasibility of DRs as a long-term solution. The acceptability of DRs in developing
countries reflects the dialectics that characterize those countries' response to intel-
lectual property, especially in the context of its application to traditional knowl-
edge. Despite their characteristic suspicion and ambivalent attitude regarding
intellectual property, they find DRs to be one means by which to address aspects
of their concerns. Finally, the willingness of developed and developing countries
to consider DRs tacitly affirms the reality of cultural cosmopolitanism and the
melding of information across knowledge systems, a phenomenon that is well re-
flected in most patents involving genetic resources. This is true particularly in
light of traditional medicines' dependence on plant and animal genetic resources.
In a sense, that dependence has some correlation with the restriction of DRs to
patents dealing with the use of genetic resources and associated traditional knowl-
edge. Next, we examine the place of GIs in this matrix.
B. Geographical Indications
Similar to DRs, GIs provide an important, albeit inadequate, site for giving
some balance to the TRIPS Agreement and the WTO process in regard to cultural
knowledge and products originating from developing countries.33 Unlike DRs, GIs
are accommodated under the TRIPS Agreement.3 According to Article 22 (1) of
TRIPS, GIs are "indications which identify a good as originating in the territory of
a Member... where a given quality, reputation or other characteristic of the good is
essentially attributable to its geographical origin."'35 Simply stated, a GI is a trade-
mark-like form of protection of the integrity, specialty, and commercial value of
products whose uniqueness is incidental to their geographical origin and customary
process of manufacture.'36 The recognition of GIs in the international intellectual
133. See Michael Blakeney, Proposals for the International Regulation of Geographical Indications,
4 J. WORLD INTELL. PROP. 629, 646-52 (2001); Calboli, supra note 118, at 200; Jos6 Manuel Corts
Martin, TRIPS Agreement: Toward a Better Protection for Geographical Indications?, 30 BRooK. J.
INT'L L. 117, 175-83 (2004); Soam,supra note 118, at 679-82; Sunder,supra note 4, at 297.
134. In comparison to other pre-TRIPS regimes on GIs, TRIPS elaborates an ambitious provi-
sion on GI that characterizes that regime as "a true milestone in this respect." Calboli, supra note
118, at 190.
135. See also Articles 23 and 24 of TRIPS for additional provisions on GIs.
136. See Calboli, supra note 118, at 184 (exploring different definitions of Gl and proffering her
own definition as "names that identify agricultural or other products as originating from the spe-
cific geographical regions in which these products are grown and manufactured, and from which
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property regime predates the TRIPS Agreement, reflecting the strong historic and
ongoing support for GIs in Europe.' Given TRIPS' disregard for indigenous or
local knowledge, its provisions on GIs assume heightened significance. Notably,
they have become a vent for channeling the desires of indigenous and local commu-
nities to remedy the inadequacies of the TRIPS Agreement in specific regard to the
recognition and protection of their cultural and agricultural products. 3 '
However, developing countries are caught at the crossroads of the regional
power play between Europe and the United States over GIs. 3 ' This tension has
stalled the expansion of the scope of protection for GIs beyond wines and spirits,
and the establishment of an international registry for GIs pursuant to TRIPS.'
they derive their qualities and reputation"). Seealso WIPO,About Geographical Indications, http://
www.wipo.int/geojindications/en/about.html (last visited July 12, 2008) (explaining that GI is "a
sign used on goods that have a specific geographical origin and possess qualities, reputation or
characteristics that are essentially attributable to that place of origin. Most commonly, a geograph-
ical indication includes the name of the place of origin of the goods. Agricultural products typi-
cally have qualities that derive from their place of production and are influenced by specific local
factors, such as climate and soil. Whether a sign functions as a geographical indication is a matter
of national law and consumer perception."). For further definitional insights on GI and its meta-
morphoses, see Calboli,supra note 118, at 184 & nn. 14-16 (citing Felix Addor & Alexandria Grazi-
oli, Geographical Indications Beyond Wines and Spirits: A Roadmap for a Better Protection for
Geographical Indications in the WTOITRIPS, 5 J. WORLD INTELL. PROP. 865, 867-69 (2002)).
137. For a concise account of the European-championed evolution of the protection of GIs in
their diverse designations under various international instruments pre-TRIPs (i.e. the Paris Con-
vention for the Protection of Industrial Property, the Madrid Agreement for the Repression of
False and Deceptive Indications of Source on Goods and the Lisbon Agreement for the Protection
of Appellations of Origin and their International Registration), their partial successes, failures and
limitations, as well as the TRIPS framework for GIs, see Calboli, supra note 118, at 187-97. See
generally Lee Bendekgey & Caroline H. Head, International Protection ofAppellations of Origin and
Other Geographical Indications, 82 TMR 765 (1992) (noting that longer established industrialized
nations in Europe and the former Soviet Union have a vested interest in establishing origin specific
brand recognition).
138. See generally Ralph S. Brown, New Wine in Old Bottles: The Protection of France'; Wine Classi-
fication System Beyond Its Borders, 12 B.U. INT'L L.J. 471 (1994) (noting with dismay the inadequate
protection given to premium wines and wine regions in the United States and elsewhere). See also
Calbolisupra note 118, at 197; Martin,supra note 133, at 175; Sundersupra note 4, at 298-303.
139. Simply stated, America's reservation over strong GIs is that it undermines the use of names
that have now acquired generic status, and that forcing countries to abandon such names would be
very difficult and costly. Also, the United States fears that a strong GI will benefit European coun-
tries that have had pre-existing national legal regimes for GI protection in comparison to America
and the developing countries who are latecomers to the GI concept. For an outline of arguments
for and against minimalist and maximalist GI protection, see Calboli, supra note 118, at 142-64.
140. Article 23 requires member states to enact national laws to protect GIs in specific regard to
wines and spirits even if such protection constitutes unfair competition, which is prohibited under
Article 10bis of the Paris Convention. Also, it clearly privileges GIs over trademarks that contain
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The attractiveness of GIs may outweigh the opposition to it, as illustrated by the
record growth of Australia's wine industry, which has turned that country into a
GI convert.4 In addition, a coalescing of developing countries and European in-
terests in strong protection of GIs continues to strengthen global interest in GIs."'
Meanwhile, key opponents of GIs, such as the United States, have not yet fully
explored TRIPS built-in exemptions'43 to GIs that encapsulate a European com-
promise to limit GI protection, a concession that may well facilitate a diplomatic
reprieve"4 for the GI logjam. Apparently, this is what is required for developing
countries and other stakeholders to take advantage of the potential which TRIPS
has created for GIs.
Despite France's longstanding influence in TRIPS negotiations on GIs with
the aim to protect its wines and champagnes, GIs are increasingly becoming an
important asset for developing countries in the projection and protection of their
unique cultural products in an increasingly globalized marketplace. For some,
GIs represent a unique meeting point for CBD's proactive program for protection
of biodiversity and local knowledge, and the WTO's trade regime in the interface
between environment, trade, and development. Writing in reference to India's GI
regime, which is strikingly popular among that country's local and poor commu-
nities, Sunder notes that:
GI relating to wines and spirits. Article 23(4) provides for post-TRIPS negotiations for setting up
a multilaterally harmonized system for notification and registration of GIs in regard to wines and
spirits. Article 24, inter alia, generally provides for further negotiations around GI at the TRIPS
Council. Attempts to revisit GIs at that Council from the 2001 Doha Rounds of multilateral trade
negotiations (development rounds) and the Cancun Summit in Mexico, has not resulted in any
significant progress. See Calboli,supra note 118, at 194 (citing Martin, supra note 133, at 141-42).
141. See generally Calboli,supra note 118 (noting that following Australia's 1994 bilateral agree-
ment with the European Union, that country dropped the use of French regions such as Burgundy
or Chablis to describe its wines. The decision resulted in the birth of an authentic Australian wine
industry which relies on Australia's regional names. Consequently, in 2003, Australia marked the
first time its wines outsold French wines in both Britain and the United States).
142. See Calboli,supra note 118, at 195 (noting that in the last ten years Europe has continued to
promote maximalist protection for GIs while the United States, Canada, and Australia remain
opposed, and that "interestingly developing countries have increasingly taken sides with the Euro-
pean Union").
143. Notable exemptions are provided under the grandfather clause in Article 24(4), (5), which
saves GIs used for some length of time before TRIPS, the use of Gl in a Member country in good
faith, and trademarks containing or consisting of GIs but used in good faith pre-TRIPS or before
the protection of associated GI in a Member country. Finally, Article 46(6) saves the use of Gls that
have acquired status as generic names.
144. See generally Calboli, supra note 118 (outlining "old" world efforts to ensure continued ex-
pansion of protection for GIs).
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[TIhe turn to intellectual property for the poor is not simply an-
other instance of a misguided "if value, then right" mentality...
poor people's turn to property is surely about economics, but is
about social and cultural values as well. These claims recognize
that the relationship between intellectual property and develop-
ment goes beyond GDP. People, rich and poor alike, want recogni-
tion of their creativity and contributions to science and culture. 14 5
From Native Americans in the United States, Canadian First Nations, and
several aboriginal communities in Australia and elsewhere, to indigenous or tra-
ditional communities in Mexico, India, Ethiopia, and most of the developing
countries, GIs have potential and real significance for the economic empower-
ment of local communities, their unique art works, and their ecologically endemic
range of traditional or cultural products including coffee,146 tea, fruits, food crops,
and other agricultural products.'47 Pending negotiations on the expansion of GI
145. Sunder, supra note 4, at 301 (footnotes omitted). See generally Soam, supra note 118 (for a
detailed analysis of the significance and prospects of India's new GIs regime, which came into ef-
fect in 2003).
146. The Ethiopian government's proactive role in reclaiming and branding three types of Ethi-
opian grown coffee after the three regions where they are grown, is an example of the growing
developing country interest in trademark-like rights for their geographically sensitive products.
(This appears to be a stop-gap measure in place of botched negotiations on the extension of TRIPS
protection to GIs beyond wines and spirits pursuant to Article 24). The names are Yirgacheffe,
Harrar, and Sidamo, which also correspond to the country's highly reputed coffee growing re-
gions. Ethiopia prevailed over opposition from Starbucks to register these names globally as trade-
marks in Europe, the United States, Canada, Japan and elsewhere. Interestingly, Starbucks had to
abandon its earlier attempt to register Sidamo as a coffee brand at the USPTO and CIPO (Cana-
dian Intellectual Property Office). Grudgingly, along with other multinational coffee and other
beverages, Starbucks is a participant in the franchising/licensing arrangement which the Ethio-
pian government now pursues with multinational interests on its brands of coffee. In June 2007,
the Ethiopian government and Starbucks brokered a deal for the distribution and marketing of its
specific GIs coffee brand. For Ethiopia's success story, see Alexia Garamfalvi, Ethiopian Coffee
Trademark Dispute with Starbucks Runs Hot and Cold, LEGAL TIMES, Mar. 6, 2007, available at
http://www.law.com/jsp/article.jsp?id= 1173261800496. See also Ethiopian Coffee Licensing, http://
www.ethiopiancoffeenetwork.com/licensing.shtml (last visited July 12, 2008).
147. Samples of GIs success stories in developing countries include Darjeeling tea and Rooibos tea.
Darjeeling tea is grown in Darjeeling, India, which is noted for its unique geographical and climatic
condition. The tea, which is one of the world's most expensive, is noted for its unique flavor and
aroma that compares to no other. Rooibos tea (aka red bush tea), grown only in the Cedarberg region
and parts of Clanwilliam and Citrusdal in South Africa, is made by fermenting the sun-dried leaves
of the red Rooibos bush and is associated with elements that prevent the death of brain cells and
growth of cancer cells. See Soam, supra note 118, at 689-90; Sunder, supra note 4, at 303.
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protection beyond wines and spirits under TRIPS, developing countries, like
India, have continued to take advantage of current rules to enact specific legisla-
tion on GIs, or to explore alternatives similar to GIs, such as trademarks or certi-
fication marks, for their geographically sensitive agricultural products.' 45
Unlike TKDL and DRs, GIs are a trademark-like protection that does not
directly involve patents. ' However, it represents part of the broader scheme in
which indigenous and local communities have taken the opportunity to push for
the accommodation of their knowledge within the conventional intellectual prop-
erty protection scheme. In today's postmodern environment, there is, on a global
scale, a voracious appetitive for exoticism and romanticism around cultural prod-
ucts from "pristine" communities. This phenomenon is a practical translation of
cultural cosmopolitanism in our increasingly networked and borderless commer-
cial world. In a way, it also demonstrates the softening of the divisions along
epistemic lines that characterize the relationship between traditional knowledge
and Western scientism.
In the context of traditional medicine, specific medicines, and traditional me-
dicinal practices, herbs or herbal preparations may be the subjects of GIs. But the
standardization or certification required for the success of GIs and the intertwining
of products, process, and services in traditional medicine go to show that GIs may
have a challenging role to play in their protection. 5 ' Nonetheless, the postmodern
fascination with natural health products, naturaceuticals, or "food medicines,"
herbal medicines, and traditional medicine in general, is a further affirmation for
cultural cosmopolitanism. Consequently, the market and intellectual property po-
tential of traditional medicine-related products make GIs quite attractive.
Implementation of a GI regime in a developing country is a difficult and
complex exercise. For instance, GI is a capital intensive endeavor, requiring an
elaborate structure for the control of market power to nurture, brand, and popu-
larize susceptible local products to ensure their global reach and acceptability.
148. In 1999, India enacted The Geographical Indications of Goods (Registration and Protec-
tion) Act as, perhaps, one of the most effective ways to protect that country's rich cultural heritage
and an attempt to empower its diverse artisan and small scale agricultural communities "to remain
in their villages, resisting the pull of city industries." Sunder, supra note 4, at 300.
149. As a matter of distinction, trademark gives its owner the right to exclude others from using
the trademark or sign of another, effectively distinguishing the goods and services of one enter-
prise from another, whereas "a geographical indication tells consumers that a product is produced
in a certain place and has certain characteristics that are due to that place of production" and may
be deployed by producers or manufacturers of that common region. WIPO, supra note 136.
150. Eiland,supra note 39, at 73.
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Many indigenous and local communities whose products are subjects of GIs can
hardly boast of the historically entrenched market niches and power associated
with "champagne" and other products already protected by GIs. This situation
requires some rethinking in those countries that have implemented GIs, such as
India, as to whether manufacturing GI products should be limited strictly to his-
toric communities, or be allowed to take place outside those communities. 5' An
argument in support of the latter is that ex-situ manufacture of GI products will
accommodate migration-driven cultural cosmopolitanism. In addition, ex-situ
manufacturing could also accommodate the possibility of franchising around
products that are subjects of GIs. 5 2 According to S. K. Soam, "it is a widely ac-
cepted fact that whenever people go to other places they bring along some product
(such as sweets, textiles, handicrafts, artifacts, etc.) that has a specific reputation
due to its association with its place of origin." '53 Except where climatic, ecological,
and cultural constraints are fundamental to the character and process of manu-
facture of a product, there is perhaps little reason why when people migrate, they
should not take with them cultural practices and peculiar skills associated with
the manufacture of GI products. 54 These are important issues for consideration,
especially given that countries that were reluctant converts to GIs, such as the
United States, have embarked on an aggressive branding around GIs in ways that
could undermine whatever benefit indigenous and local communities stand to
gain in the use of GIs. To compete in the present GI environment, and to fully
maximize the window of opportunity for GIs provided in the TRIPS Agree-
151. The Indian Geographical Indication of Goods (Registration and Protection) Act, 1999, pro-
hibits the licensing of GIs and insists upon GI goods being exclusively limited to a specific geo-
graphic environment. Sunder, supra note 4, at 302. According to Sunder, "Such requirements and
restrictions take a narrow view of traditional knowledge, [by] linking culture to land," and that
such restrictions neglect the fact that "People move, intermarry, and change jobs. Culture flows
with them. The GI Act does not recognize this dynamic nature of culture, ossifying authentic
production in today's localities." Id. (footnotes omitted).
152. But see Calboli, supra note 118, at 185 (arguing that GI cannot be licensed because their
uniqueness strictly depends on their tie with the geographical place they identify).
153. Soam, supra note 118, at 679.
154. Ironically, when immigrants carry on with products or manufacturing processes subject to
GI, it can be argued that "[alfter some time the link between the territory from which the prod-
ucts originated and their names [could be] forgotten, and the term that were used to identify these
products [could enteri the common language as the generic name of the products rather than the
name of their geographic origin." Calboli, supra note 118, at 198 (citing Molly Torsen, Apples and
Oranges (and Wine): Why the International Conversation Regarding Geographic Indications is at a
Standstill, 87 J. PAT. & TRADEMARK OFF. Soc'Y 31, 51-60 (2005)).
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ment, developing countries need to be pragmatic and responsive to keep up with
the adoption and use of GIs in established economies.
In sum, despite their increasing patronage by developing countries in the
post-TRIPs era, GIs seem to possess limited application to traditional medicine.
Obviously, GIs speak to a different intellectual property regime than patents.
However, as noted, the application of GIs to cultural products and their patronage
reflects cultural cosmopolitanism, making GIs yet another demonstration of
progress in the opening up of the intellectual property system to the pressures
exerted by traditional knowledge, including traditional medicine, for appropriate
recognition and admission into that regime on their own terms.
CONCLUSION
In the last decade since TRIPS and CBD, scholars, indigenous and local
community activists, and various stakeholders have decried the irreconcilable na-
ture of intellectual property with local knowledge forms. Much ink has been
spilled in analyzing this perceived hopeless state of affairs in the search for a pol-
icy direction to empower local knowledge forms. Yet, little to no concrete results
have emerged. In that preoccupation, it has been quite easy to ignore or lose sight
of the fact that some progress, however infinitesimal, has been made in the effort
to bring local knowledge closer to the ambit of the intellectual property system.
However, local knowledge continues to be frittered away in a unidirectional
flow from local communities to Western industrial complexes, mainly through ac-
tivities generally described as biopiracy. The skeptical and often dialectical relation-
ship which had characterized the attitude of local knowledge custodians to the
intellectual property system is gradually wearing thin for want of a more pragmatic
approach. This is more so as the melding of knowledge systems awakens stakehold-
ers to the reality of cultural cosmopolitanism and globalization. The hardened lines
of division and categorization between knowledge systems are no longer strictly sus-
tainable, given the traffic across knowledge and cultural systems around the world.
Both globalization and the challenge of biopiracy have opened new opportu-
nities for pragmatic initiatives to breach and bridge the seemingly impenetrable
barrier between local knowledge and the intellectual property system. Despite the
dialectical disposition of local communities and some developing countries to the
intellectual property system, there is notable progress in opening up local knowl-
edge, especially traditional medicine, to that system. This is exemplified in the
Indian-pioneered TKDL project which is basically an anti-appropriation initia-
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tive. The TKDL has recorded tremendous success in enhancing traditional me-
dicinal knowledge within the international patent process. Also, by way of other
nuanced policy initiatives, a number of countries, notably China, Japan, and Tai-
wan have adopted custom-specific strategies in bringing their traditional medici-
nal systems within the conventional patent framework. While there has been a
tendency to tone down the theoretical and philosophical features of TCM in the
attempt to open it into Western scientific ontology and the intellectual property
system, Taiwan has proposed a unique and creative scheme through which it
seeks to retain the theoretical essence of CHM within its patent regime.
In addition to these specific initiatives, developing countries are also willing to
take advantage of TRIPS provisions on GIs and the ongoing debates around DRs to
open up local knowledge to the intellectual property system. While strides in GIs
and DRs are inchoate, both are means for demonstrating the reality of cultural cos-
mopolitanism. GIs and DRs have no direct bearing on traditional medicine, unlike
the Indian TKDL and Taiwanese initiative. However, the interest and patronage
they attract in developing countries and in indigenous and local communities are
indicative of the overall paradigm shift that has occurred and that has positively
impacted the hitherto hopeless state of frustration arising from the perceived quan-
dary in reconciling local knowledge with the conventional patent system.
It is too early to examine the transformative impact of these initiatives in
terms of their actual empowerment of local knowledge. Nonetheless, it is difficult
to dismiss the symbolic essence of the initiatives in the overall thrust of cultural
cosmopolitanism and the dialectics of knowledge transformation. Thus far, this
development, though incremental and unpredictable in terms of sustainability,
represents the first practical steps toward stretching the conceptual framework of
intellectual property, especially the patent regime, to accommodate local knowl-
edge. It demonstrates a concrete shift from the traditional refrain that intellectual
property is irreconcilable with local knowledge.
